(Q33893117)

29 July 2017

title

Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery (English)

1 reference

29 July 2017

Zhao Dong

1

1 reference

29 July 2017

Shuyu Xie

2

1 reference

29 July 2017

Luyan Zhu

3

1 reference

29 July 2017

Yan Wang

4

1 reference

29 July 2017

Xiaofang Wang

5

1 reference

29 July 2017

Wenzhong Zhou

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

10 May 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

441-450

1 reference

Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Development of the quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective stud

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

PLGA nanoparticles in drug delivery: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Fluoroquinolones in animal health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Characterization of nanoparticle uptake by endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Gastrointestinal uptake of biodegradable microparticles: effect of particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

The fluorescence characteristic of the yttrium-norfloxacin system and its analytical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Characterization of diazepam submicron emulsion interface: role of oleic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Norfloxacin in the treatment of uncomplicated gonococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

An examination of the factors affecting intestinal lymphatic transport of dietary lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Oral solid lipid nanoparticle-based antitubercular chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

In vitro assessment of oral lipid based formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

An interview with Sir William Osler on the GPEP report. Interview by Steven L. Berk.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Bioadhesive microspheres as a controlled drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Prevention of bacterial and fungal infections in granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Norfloxacin: a new targeted fluoroquinolone antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Studies on the cyclosporin A loaded stearic acid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2011.577109

10.3109/10717544.2011.577109

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference